Life Sciences & Biotechnology
Title : | A randomized, double-blind, placebo and active controlled, multicenter, phase 3 study to access the efficacy and safety of Filgotinib administered for 52 weeks in combination with Methotrexate (MTX) to subjects with moderately to severely active rheumatoid arthritis, who have an inadequate response to methotrexate |
Area of research : | Life Sciences & Biotechnology, Medical Sciences |
Focus area : | Orthopedics |
Principal Investigator : | Dr Uma Kumar, Professor & Head, All India Institute of Medical Sciences (AIIMS), New Delhi |
Timeline Start Year : | 2018 |
Timeline End Year : | 2019 |
Contact info : | umaakumar@yahoo.co.in |
Details
Total Budget (INR): | 7,00,000 |
Organizations involved
